BAJAJ BROKING

Notification close image
No new Notification messages
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

29224

544292

ONESOURCE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ONESOURCE SPECL PHARMA L performance

Today’s low

Today’s high

₹ 1833.20 ₹ 1874.50
₹ 1843.50

52 week low

52 week high

₹ 1209.95 ₹ 2248.00
₹ 1843.50

Open Price

₹ 1865.10

Prev. Close

₹ 1868.80

Volume (Shares)

84573.00

Total traded value

₹ 1559.10

Upper Circuit

₹ 2242.50

Lower Circuit

₹ 1495.10

info

ONESOURCE SPECL PHARMA L Share Price Update

As of the latest trading session, ONESOURCE SPECL PHARMA L share price is currently at ₹ 1843.5, which is down by ₹ -25.30 from its previous closing. Today, the stock has fluctuated between ₹ 1833.20 and ₹ 1874.50. Over the past year, ONESOURCE SPECL PHARMA L has achieved a return of 9.28 %. In the last month alone, the return has been -1.63 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ONESOURCE SPECL PHARMA L fundamentals


  • Market cap (Cr)

    21,112.70

  • P/E Ratio (TTM)

    314.50

  • Beta

    1.21

  • Book Value / share

    516.92

  • Return on equity

    3.22%

  • EPS (TTM)

    15.37

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    24.82

info icon alternate text
  • Market cap (Cr)

    21,139.10

  • P/E Ratio (TTM)

    314.50

  • Beta

    1.17

  • Book Value / share

    516.92

  • Return on equity

    3.22%

  • EPS (TTM)

    15.37

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    24.82

info icon alternate text

ONESOURCE SPECL PHARMA L Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 321.01
Operating Expense 301.45
Net Profit 24.82
Net Profit Margin (%) 7.73
Earnings Per Share (EPS) 2.17
EBITDA 85.13
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 477.41
Operating Expense 306.44
Net Profit 174.19
Net Profit Margin (%) 36.48
Earnings Per Share (EPS) 15.22
EBITDA 240.85
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 336.75
Operating Expense 315.16
Net Profit -73.02
Net Profit Margin (%) -21.68
Earnings Per Share (EPS) -6.69
EBITDA 4.88
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 245.40
Operating Expense 300.76
Net Profit -57.89
Net Profit Margin (%) -23.59
Earnings Per Share (EPS) -13.93
EBITDA 19.65
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 240.03
Operating Expense 304.50
Net Profit -23.97
Net Profit Margin (%) -9.98
Earnings Per Share (EPS) -2.22
EBITDA 9.30
Effective Tax Rate (%) 63.37
Particulars MAR 2025 (Values in Cr)
Revenue 1299.59
Operating Expense 1226.48
Net Profit 19.31
Net Profit Margin (%) 1.48
Earnings Per Share (EPS) 1.75
EBITDA 274.70
Effective Tax Rate (%) 193.19
Particulars MAR 2024 (Values in Cr)
Revenue 171.92
Operating Expense 425.15
Net Profit -390.40
Net Profit Margin (%) -227.08
Earnings Per Share (EPS) -93.97
EBITDA -199.21
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 38.71
Operating Expense 312.56
Net Profit -799.11
Net Profit Margin (%) -2064.35
Earnings Per Share (EPS) -200.69
EBITDA -316.32
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 513.90
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.21
EBITDA Margin 33.51
Particulars MAR 2024 (Values in Cr)
Book Value / Share 98.68
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.22
EBITDA Margin -45.49
Particulars MAR 2023 (Values in Cr)
Book Value / Share 195.87
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.14
EBITDA Margin -410.47
Particulars MAR 2022 (Values in Cr)
Book Value / Share 333.49
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.88
EBITDA Margin -0.26
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5029.28
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.72
EBITDA Margin -328.85
Particulars MAR 2025 (Values in Cr)
Book Value / Share 517.36
ROE % 3.22
ROCE % 5.21
Total Debt to Total Equity 0.24
EBITDA Margin 29.71
Particulars MAR 2024 (Values in Cr)
Book Value / Share 99.19
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.21
EBITDA Margin -45.51
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1961.88
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.12
EBITDA Margin -298.97
Particulars MAR 2022 (Values in Cr)
Book Value / Share 259.75
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.86
EBITDA Margin -69.15
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5045.70
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.72
EBITDA Margin -332.12
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 60.32
Total Assets 1308.61
Total Liabilities 1308.61
Total Equity 395.71
Share Outstanding 40023816
Price to Book Ratio 0.00
Return on Assets (%) -29.89
Return on Capital (%) -40.84
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 79.82
Total Assets 2008.80
Total Liabilities 2008.80
Total Equity 785.45
Share Outstanding 40023816
Price to Book Ratio 0.00
Return on Assets (%) -39.81
Return on Capital (%) -49.31
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 169.73
Total Assets 2442.35
Total Liabilities 2442.35
Total Equity 1012.47
Share Outstanding 29900000
Price to Book Ratio 0.00
Return on Assets (%) -9.46
Return on Capital (%) -10.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 77.76
Total Assets 1257.80
Total Liabilities 1257.80
Total Equity 776.02
Share Outstanding 1543309
Price to Book Ratio 0.00
Return on Assets (%) -9.60
Return on Capital (%) -10.4
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 227.62
Total Assets 7390.46
Total Liabilities 7390.46
Total Equity 5920.10
Share Outstanding 114436021
Price to Book Ratio 3.38
Return on Assets (%) 0.26
Return on Capital (%) 0.29
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 60.25
Total Assets 1308.57
Total Liabilities 1308.57
Total Equity 397.74
Share Outstanding 40023816
Price to Book Ratio 0.00
Return on Assets (%) -29.83
Return on Capital (%) -40.69
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 79.76
Total Assets 2008.44
Total Liabilities 2008.44
Total Equity 786.71
Share Outstanding 40023816
Price to Book Ratio 0.00
Return on Assets (%) -39.78
Return on Capital (%) -49.22
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 169.45
Total Assets 2444.99
Total Liabilities 2444.99
Total Equity 1015.50
Share Outstanding 39096280
Price to Book Ratio 0.00
Return on Assets (%) -9.39
Return on Capital (%) -10.59
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 77.40
Total Assets 1262.17
Total Liabilities 1262.17
Total Equity 778.55
Share Outstanding 1543309
Price to Book Ratio 0.00
Return on Assets (%) -9.60
Return on Capital (%) -10.41
Particulars MAR 2025 (Values in Cr)
Net Income -67.75
Cash from Operations -60.84
Cash from Investing -201.08
Cash from Financing 412.00
Net change in Cash 143.07
Free Cash Flow 67.30
Particulars MAR 2024 (Values in Cr)
Net Income -391.16
Cash from Operations -107.21
Cash from Investing 510.54
Cash from Financing -390.54
Net change in Cash 12.79
Free Cash Flow -43.44
Particulars MAR 2023 (Values in Cr)
Net Income -799.83
Cash from Operations -173.81
Cash from Investing -67.71
Cash from Financing 118.31
Net change in Cash -112.28
Free Cash Flow -129.81
Particulars MAR 2022 (Values in Cr)
Net Income -231.16
Cash from Operations -415.88
Cash from Investing -691.60
Cash from Financing 1161.96
Net change in Cash 54.47
Free Cash Flow 239.26
Particulars MAR 2021 (Values in Cr)
Net Income -120.56
Cash from Operations -116.71
Cash from Investing -207.37
Cash from Financing 380.95
Net change in Cash 56.00
Free Cash Flow 90.72
Particulars MAR 2025 (Values in Cr)
Net Income -22.14
Cash from Operations -40.38
Cash from Investing -300.03
Cash from Financing 417.21
Net change in Cash 69.89
Free Cash Flow 45.92
Particulars MAR 2024 (Values in Cr)
Net Income -390.40
Cash from Operations -108.98
Cash from Investing 505.98
Cash from Financing -384.22
Net change in Cash 12.78
Free Cash Flow -45.22
Particulars MAR 2023 (Values in Cr)
Net Income -799.11
Cash from Operations -175.62
Cash from Investing -65.68
Cash from Financing 118.31
Net change in Cash -112.05
Free Cash Flow -133.78
Particulars MAR 2022 (Values in Cr)
Net Income -229.74
Cash from Operations -419.66
Cash from Investing -684.53
Cash from Financing 1158.74
Net change in Cash 54.54
Free Cash Flow 229.94
Particulars MAR 2021 (Values in Cr)
Net Income -121.23
Cash from Operations -114.87
Cash from Investing -210.33
Cash from Financing 380.97
Net change in Cash 55.75
Free Cash Flow 44.26
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.51 12.86 1.72 241.47 30.00 / 68.00
BLISS GVS PHARMA LTD. 152.50 15.10 1.53 1609.97 105.05 / 190.65
CIPLA LTD. 1573.80 23.57 4.07 127124.34 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 363.70 10.24 2.95 1070.41 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.51 17.13 4.97 241.47 30.00 / 68.00
AMRUTANJAN HEALTH CARE LTD. 755.35 40.05 6.68 2183.76 548.05 / 829.00
ASTRAZENECA PHARMA INDIA LTD. 9004.20 106.45 29.22 22510.50 6222.35 / 10653.05
BLISS GVS PHARMA LTD. 152.50 22.80 1.52 1609.97 105.05 / 190.65

ONESOURCE SPECL PHARMA L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1843.50 -1.35 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 1857.30
  • 26 Days 1877.80
  • 10 Days 1860.60
  • 50 Days 1889.50
  • 12 Days 1862.20
  • 100 Days 1825.00
  • 20 Days 1870.60
  • 200 Days 1739.50
1865.23 PIVOT

First Support

1841.77

First Resistance

1892.27

Second Support

1814.73

Second Resistance

1915.73

Third Support

1791.27

Third Resistance

1942.77

RSI

47.86

ADX

26.31

MACD

-15.60

Williams % R

-49.67

Commodity Channel Index (CCI)

16.52

Date

2025-09-12

Week

42504.00

Same Day

33204.00

Month

83474.00

1 Year

1.22

3 Year

1.21

Over 1 Month

-1.63%

down

Over 1 Year

9.28%

down

Over 3 Months

-5.45%

down

Over 3 Years

0.00%

down

Over 6 Months

23.79%

down

Over 5 Years

0.00%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

ONESOURCE SPECL PHARMA L shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
33.42%
Promoter Holdings
29.78%
FII
18.68%
DII
18.1%
Promoter Shares(Pledge Percentage)
25.01%
Name Shares Category
Tenshi Pharmaceuticals Private Limited 2.0524714E7 (17.93%) Shareholding of Promoter and Promoter Group
Karuna Business Solutions Llp 7890353.0 (6.89%) Shareholding of Promoter and Promoter Group
Amansa Holdings Private Limited 3788938.0 (3.31%) Public Shareholding
Motilal Oswal 3668124.0 (3.2%) Public Shareholding
Pronomz Ventures Llp 2682402.0 (2.34%) Shareholding of Promoter and Promoter Group
Route One Offshore Master Fund L.p. 2663310.0 (2.33%) Public Shareholding
Quant Mutual Fund 2488968.0 (2.17%) Public Shareholding
Route One Fund I, L.p. 2368534.0 (2.07%) Public Shareholding
360 One Special Opportunities Fund - Series 12 1852688.0 (1.62%) Public Shareholding
Arco Lab Private Limited 1839900.0 (1.61%) Shareholding of Promoter and Promoter Group
Sbi Life Insurance Co. Ltd 1598669.0 (1.4%) Public Shareholding
Smallcap World Fund, Inc 1560571.0 (1.36%) Public Shareholding
Axis Mutual Fund 1150671.0 (1.01%) Public Shareholding
Arun Kumar Pillai 970497.0 (0.85%) Shareholding of Promoter and Promoter Group
Padmakumar Karunakaran Pillai 43242.0 (0.04%) Shareholding of Promoter and Promoter Group
Vineetha Mohanakumar Pillai 47500.0 (0.04%) Shareholding of Promoter and Promoter Group
Sajitha Pillai 35000.0 (0.03%) Shareholding of Promoter and Promoter Group
Rajitha Gopalakrishnan 30000.0 (0.03%) Shareholding of Promoter and Promoter Group
Aditya Arun Kumar 29211.0 (0.03%) Shareholding of Promoter and Promoter Group
Hemalatha Pillai 3380.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

ONESOURCE SPECL PHARMA L corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

ONESOURCE SPECL PHARMA L Share Price

Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore. The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies. The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,. Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.

A Scheme of Arrangement amongst Strides Pharma Science Limited, Steriscience Specialties Private Limited and the Company and their respective shareholders and creditors was implemented on November 14, 2024. Prior to the Scheme of Arrangement, Strides Pharma Science Limited, Steriscience Specialties Private Limited were involved in the businesses of biologics and DDC, soft gelatin capsule and injectables business, respectively.

Pursuant to the Scheme, Strides Pharma Science Limited, Steriscience Specialties Private Limited got transferred / demerged to and vested with the Company as a going concern effective on April 1, 2024 and the Scheme was made effective from November 27, 2024 with the Registrar of Companies. In accordance with the Scheme of Arrangement, 11,44,36,021 Equity Shares of Re. 1/- each have been allotted and issued.

At present, Company is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. It also offers end-to-end Contract Development and Manufacturing Operations (CDMO) services across all phases of pre-clinical and clinical development and commercial supply of biologics. Company has 5 globally compliant Manufacturing Facilities. Customer list includes some of the top pharmaceutical generic companies, innovator pharmaceutical and biopharmaceutical companies, small biotechs and dedicated R&D houses, spread across the globe.

Parent organization Indian Private
NSE symbol ONESOURCE
Founded 2007
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of OneSource Specialty Pharma Ltd?

Answer Field

OneSource Specialty Pharma Ltd share price is for NSE ₹ 1,843.50 & for BSE ₹ 1,842.75 as on Sep 15 2025 03:30 PM.

What is the Market Cap of OneSource Specialty Pharma Ltd Share?

Answer Field

The market cap of OneSource Specialty Pharma Ltd for NSE ₹ 7,378.39 & for BSE ₹ 7,375.38 as on Sep 15 2025 03:30 PM.

What is the 52 Week High and Low of OneSource Specialty Pharma Ltd?

Answer Field

The 52 Week High and Low of OneSource Specialty Pharma Ltd for NSE is ₹ 2,248.00 and ₹ 1,209.95 and for BSE is ₹ 2,249.65 and ₹ 1,163.05.

What is 1 year return for OneSource Specialty Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 9.28%.

What is the P/E Ratio of OneSource Specialty Pharma Ltd Share?

Answer Field

As on Sep 15 2025 03:30 PM the price-to-earnings (PE) ratio for OneSource Specialty Pharma Ltd share is 314.50.

What is the PB ratio of OneSource Specialty Pharma Ltd Share?

Answer Field

As on Sep 15 2025 03:30 PM, the price-to-book (PB) ratio for OneSource Specialty Pharma Ltd share is 516.92.

How to Buy OneSource Specialty Pharma Ltd Share?

Answer Field

You can trade in OneSource Specialty Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy OneSource Specialty Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy OneSource Specialty Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “OneSource Specialty Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91